An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model

BMC Veterinary Research

Volumn 5, Issue , 2009, Pages

  Macrory, Lisa ^a   Vaughan Thomas, Anne ^a   Clegg, Peter D ^a   Innes, John F ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

COLLAGEN; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEOGLYCAN; PYRAZOLE DERIVATIVE; TEPOXALIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; ARTICULAR CARTILAGE; DOG; DRUG EFFECT; METABOLISM; TISSUE CULTURE TECHNIQUE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; COLLAGEN; CYTOKINES; DOGS; PROTEOGLYCANS; PYRAZOLES; TISSUE CULTURE TECHNIQUES;

EID: 70149097394     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-5-25     Document Type: Article

References (30)

1. Paradis M, Sauve F, Charest J, Refsal KR, Moreau M, Dupuis J. Effects of moderate to severe osteoarthritis on canine thyroid function. Can Vet J-Rev Vet Can 2003, 44(5):407-412.
2. Roughley PJ. Articular cartilage and changes in arthritis - Noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Research 2001, 3(6):342-347. 128909, 11714388, 10.1186/ar326.
3. Matyas JR, Ehlers PF, Huang DQ, Adams ME. The early molecular natural history of experimental osteoarthritis - I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. Arthritis Rheum 1999, 42(5):993-1002. 10.1002/1529-0131(199905)42:5<993::AID-ANR19>3.0.CO;2-U, 10323456.
4. Innes JF, Little CB, Hughes CE, Caterson B. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis. Am J Vet Res 2005, 66(10):1679-1685. 10.2460/ajvr.2005.66.1679, 16273897.
5. Pratta MA, Scherle PA, Yang GJ, Liu RQ, Newton RC. Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein. Arthritis Rheum 2003, 48(1):119-133. 10.1002/art.10726, 12528112.
6. Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM, Fosang AJ. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 2007, 117(6):1627-1636. 1866253, 17510707, 10.1172/JCI30765.
7. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, Spaull JR, Goldring MB, Koshy PJT, Rowan AD, et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998, 41(10):1760-1771. 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M, 9778217.
8. Catterall JB, Carrere S, Koshy PJ, Degnan BA, Shingleton WD, Brinckerhoff CE, Rutter J, Cawston TE, Rowan AD. Synergistic induction of matrix metalloproteinase 1 by interleukin-1 alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 2001, 44(10):2296-2310. 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9, 11665970.
9. Rowan AD, Koshy PJ, Shingleton WD, Degnan BA, Heath JK, Vernallis AB, Spaull JR, Life PF, Hudson K, Cawston TE. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 2001, 44(7):1620-1632. 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B, 11465713.
10. Tyler JA, Saklatvala J. Pig interleukin-1 (catabolin) induces resorption of cartilage proteoglycan and prevents synthesis of proteoglycan and collagen. Br J Rheum 1985, 24(S1):150-155.
11. Tyler JA, Benton HP. Synthesis of type-II collagen is decreased in cartilage cultured with interleukin-1 while the rate of intracellular degradation remains unchanged. Coll Rel Res 1988, 8(5):393-405.
12. Little CB, Flannery CR, Hughes CE, Goodship A, Caterson B. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis Cart 2005, 13(2):162-170.
13. Donaldson F, Vaughan-Thomas A, Clegg PD, Carter SD, Mobasheri A, Innes JF. Increased expression and total activity of collagenase does not correlate with collagen degradation from cytokine-treated equine cartilage explants. Int J Exp Path 2005, 86(6):A93-A93.
14. Benton HP, Vasseur PB, BroderickVilla GA, Koolpe M. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes. Am J Vet Res 1997, 58(3):286-292.
15. Palmoski M, Brandt K. In vivo effects of aspirin on canine osteoarthritic cartilage. Arthritis Rheum 1983, 26:994-1001. 10.1002/art.1780260808, 6882492.
16. Jovanovic DV, Fernandes JC, Martel-Pelletier J, Jolicoeur FC, Reboul P, Laufer S, Tries S, Pelletier JP. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis - Suppression of collagenase 1 and interleukin-1 beta synthesis. Arthritis Rheum 2001, 44(10):2320-2330. 10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P, 11665972.
17. Pelletier JP, Lajeunesse D, Jovanovic DV, Lascau-Coman V, Jolicoeur FC, Hilal G, Fernandes JC, Martel-Pelletier J. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 2000, 27(12):2893-2902.
18. Pelletier JP, Boileau C, Boily M, Brunet J, Mineau F, Geng CS, Reboul P, Laufer S, Lajeunesse D, Martel-Pelletier J. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 2005, 7(5):R1091-R1102. 1257437, 16207326, 10.1186/ar1788.
19. Rainsford KD, Ying C, Smith F. Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: Comparison with interleukin-1-synthesis inhibitors. J Pharm Pharmacol 1996, 48(1):46-52.
20. Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M - A time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002, 46(4):961-967. 10.1002/art.10212, 11953973.
21. Cawston TE, Ellis AJ, Humm G, Lean E, Ward D, Curry V. Interleukin-1 and Oncostatin-M in Combination Promote the Release of Collagen Fragments from Bovine Nasal Cartilage in Culture. Biochem Biophys Res Comm 1995, 215(1):377-385. 10.1006/bbrc.1995.2476, 7575616.
22. Willburger RE, Wittenberg RH, Schmidt K, Kleemeyer KS, Peskar BA. Antiinflammatory effect of tepoxalin - Blood and synovial tissue studied in patients with knee arthrosis. Acta Ortho Scand 1998, 69(3):295-300.
23. Farndale RW, Buttle DJ, Barrett AJ. Improved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
24. Mastbergen SC, Jansen NW, Bijlsma JW, Lafeber F. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res Ther 2006, 8(1). 1526565, 16356188.
25. Goldring MB, Goldring SR. Osteoarthritis. Journal of Cellular Physiology 2007, 213:626-634. 10.1002/jcp.21258, 17786965.
26. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008, 22(2):351-384. 10.1016/j.berh.2008.02.001, 18455690.
27. Mastbergen SC, Bijlsma JW, Lafeber FP. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthritis Cart 2005, 13(6):519-526.
28. Willburger RE, Wittenberg RH, Kleemeyer KS, Hoos R, BrunnerFeber FL, Peskar BA. Inhibition of eicosanoid release from synovial organ culture by incubation with tepoxalin and its acid metabolite. Prostaglandins 1996, 52(4):327-338. 10.1016/S0090-6980(96)80001-H, 8936587.
29. Marcouiller P, Pelletier JP, Guevremont M, Martel-Pelletier J, Ranger P, Laufer S, Reboul P. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: Regulating factors for interleukin 1 beta synthesis. J Rheumatol 2005, 32(4):704-712.
30. He W, Pelletier JP, Martel-Pelletier J, Laufer S, Di Battista JA. Synthesis of interleukin 1 beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: Interactions with anti-inflammatory cytokines. J Rheumatol 2002, 29(3):546-553.